Russia Viscosupplementation Market

Russia viscosupplementation sales will expand through 2036, with non-animal hyaluronic acid at 58.0% of source demand, high molecular weight at 51.0% of molecular weight demand and hospital procurement at 47.0% of channel demand in 2026. The market was valued at USD 58.9 million in 2026, reaching USD 103.6 million by 2036 at a 5.8% CAGR.